medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2024, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2024; 22 (4)

Dermatomyositis associated with neuroendocrine carcinoma: A case report

Flores RDY, Rivera PDA, Padilla IA, Fuentes SA, Mairena GGC

Language: Spanish
References: 40
Page: 318-327
PDF size: 290.00 Kb.


ABSTRACT

In patients with dermatomyositis, it is known that there is a higher risk of association with malignant pathology without knowing a precise cause of this association. They have been described in both solid and hematological tumors. We present the case of a 74-year-old woman diagnosed with dermatomyositis, in whom a paratracheal mass and liver lesions were found, leading to the diagnosis of neuroendocrine carcinoma.


REFERENCES

  1. Bendewald MJ, Wetter DA, Li X y Davis MD, Incidence of dermatomyositisand clinically amyopathic dermatomyositis: apopulation-based study in Olmsted county, Minnesota, ArchDermatol 2010; 146:26-30.

  2. Callen JP y Wortmann RL, Dermatomyositis, Clin Dermatol2006; 24:363-73.

  3. Fardet L, Dupuy A, Gain M et al., Factors associated with underlyingmalignancy in a retrospective cohort of 121 patients withdermatomyositis, Medicine 2009; 88:91-7.

  4. Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ y LuoSF, Incidence, cancer risk and mortality of dermatomyositis andpolymyositis in Taiwan: a nationwide population study, Br J Dermatol2011; 165:1273-9.

  5. Bohan A y Peter JB, Polymyositis and dermatomyositis: sirst oftwo parts, nejm 1975; 292:344-7.

  6. Laccarino L, Ghirardello A, Bettio S et al., The clinical features,diagnosis and classification of dermatomyositis, J Autoimmun2014;48-9.

  7. Ahmed S, Concha JSS, Chakka S et al., Diagnosing muscle diseasein a cohort of classic dermatomyositis patients seen at arheumatologic dermatology outpatient clinic, J Am Acad Dermatol2022; 86:544-50.

  8. András C, Ponyi A, Constantin T et al., Dermatomyositis andpolymyositis associated with malignancy: a 21-year retrospectivestudy, J Rheumatol 2008; 35:438-44.

  9. Hill CL, Zhang Y, Sigurgeirsson B et al., Frequency of specificcancer types in dermatomyositis and polymyositis: a population-based study, Lancet 2001; 357:96-100.

  10. Olazagasti JM, Báez PJ, Wetter DA et al., Cancer risk in dermatomyositis:a meta-analysis of cohort studies, Am J ClinDermatol 2015; 16:89-98.

  11. Cuthbertson DJ, Shankland R y Srirajaskanthan R, Diagnosisand management of neuroendocrine tumours, Clinical Medicine2023; 23:119-24.

  12. McCombs RP y MacMahon HE, Dermatomyositis associateswith metastasizing bronchogenic carcinoma; a clinicopathologicalconference, Med Clin North Am 1947; 31:1148-62.

  13. Williams RT, Carcinoma of the bronchus with hyponatraemiaand dermatomyositis, bmj 1963; 1:233-6.

  14. Fairlamb D y Boesen E, Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung, Postgrad Med J1977; 53:269-71.

  15. Lightman NI, Shield L y Siegelman SS, Neuromuscular diseaseand the chest, jama 1977; 238:2638-40.

  16. Rose JD, Membranous glomerulonephritis, dermatomyositis,and bronchial carcinoma, bmj 1979; 2:641.

  17. Chee YC, Small cell carcinoma of lung: a prospective clinicalstudy, Ann Acad Med Singapore 1985; 14:450-6.

  18. Sakuragi T, Oshita F, Nagashima S et al., Retrospective analysisof the treatment of patients with small cell lung cancer showingpoor performance status, Jpn J Clin Oncol 1996; 26:128-33.

  19. Labinjoh C y Selby C, Dermatomyositis associated with smallcell carcinoma of the lung: dramatic response to corticosteroidtherapy, Respir Med 1998; 92:601-6.

  20. Antonioli CM y Airò P, Dermatomyositis associated with lymphoproliferativedisorder of nk cells and occult small cell lungcarcinoma, Clin Rheumatol 2004; 23:239-41.

  21. Murakami Y, Kanazawa K, Okuno K et al., High-grade neuroendocrinecarcinoma of the lung presenting an unusual spreadmimicking pleural mesothelioma associated with dermatomyositis,Am J Med Sci 2004; 327:227-30.

  22. Mori H, Habe K, Hakamada A, Isoda K y Mizutani H, Relapse ofdermatomyositis after 10 years in remission following curativesurgical treatment of lung cancer, J Dermatol 2005; 32:290-4.

  23. Yasuda E, Takeshita A, Murata S et al., Neuroendocrine carcinomaof the liver associated with dermatomyositis: autopsy caseand review of the literature, Pathol Int 2006; 56:749-54.

  24. Zangrilli A, Papoutsaki M, Bianchi L, Teoli M y Chimenti S, Bullousdermatomyositis: a marker of poor prognosis and aggressiveinternal malignancy?, Acta Derm Venereol 2008; 88:393-4.

  25. Piovesan DM, Silva VD, Reichel CL et al., Neuroendocrine pancreatictumor and dermatomyositis, Pancreas 2010; 39(5):684.

  26. Chao G, Fang L, Lu C y Chen Z, Small cell lung cancer presentingas dermatomyositis: mistaken for single connective tissuedisease, Rheumatol Int 2011; 32:1737-40.

  27. Lee WY, Kastelik J, Campbell A, Avery G, McGivern D y LindM, A case report of dermatomyositis associated with small celllung cancer, Tumori 2012; 98:158-61.

  28. Nikolaos T, Maria T, Ioannis KD et al., Dematomyositis as an earlymanifestation and a significant clinical precursor of lung cancer:report of a rare case and review of the current literature, IntJ Clin Exp Med 2013; 6:105-9.

  29. Albert TJ, Bastawrous S, Raugi GJ y Hirschmann JV, A 62-yearoldman with skin rash and an abnormal chest radiograph, Chest2015; 147:90-4.

  30. Takashima R, Takamatsu K, Shinkawa Y et al., Dermatomyositisassociated with lung neuroendocrine carcinoma, Intern Med J2017; 56:719-24.

  31. Varedi D, Frigerio A, Scaife C y Hull C, A novel case of tif1 gammaautoantibody positive dermatomyositis associated with anon-functional pancreatic neuroendocrine tumor, Dermatol OnlineJ 2019; 25:3-6.

  32. Shani U, Lavine N, Houri-Levi E, Watad A y Amital H, Two casesof dermatomyositis associated with neuroendocrine tumors, IntCancer Conf J 2023; 31:17-21.

  33. Hounoki H, Onose T, Yamazaki M, Asano R, Yamaguchi S, ShinodaK et al., A case report of anti-tif1-γ antibody-positive dermatomyositisconcomitant with small cell neuroendocrine carcinomaof the urinary bladder, Case Rep Rheumatol 2023; 2023:1-5.

  34. Minagawa H, Kawai T, Matsumoto A, Makino K, Sato Y, NagasakaK et al., Dermatomyositis associated with prostate adenocarcinomawith neuroendocrine differentiation, bmc Urol 2021;7:1-8.

  35. Wang Y, Zhao BT, Jia XJ, Zhang MM, Jiang DL, Li WL y Xie XJ,Pancreatic neuroendocrine carcinoma with dermatomyositis: acase report, Zhonghua Nei Ke Za Zhi 2021; 60:373-5.

  36. Yildirim R, Dinler M, Erdog˘ an B, Dündar E, Bilge NS˛Y y Kas˛ifog˘ lu T, A rare cause of dermatomyositis: large cell neuroendocrinetumor of the lung, Int J Rheum Dis 2023; 26:805-7.

  37. Papagoras C, Arelaki S, Botis I, Chrysafis I, Giannopoulos S ySkendros P, Co-occurrence of dermatomyositis and polycythemiaunveiling rare de novo neuroendocrine prostate tumor,Front Oncol 2018; 8:534.

  38. Azuma N, Satoh T, Kawaguchi S, Oshima T, Muro H y Taku K, Acase of jejunal neuroendocrine carcinoma complicated with dermatomyositis,Nihon Shokakibyo Gakkai Zasshi 2018; 115:1063-8.

  39. Ahumada PH, Fuentes CL, Selamé GR, García OD, Jiménez AA,Durán HC, Ávila Pérez J y Cortés Latorre M, Dermatomiositiscomo primera manifestación de un carcinoma de células pequeñas:caso clínico y revisión de la literatura, Medwave 2016;10:15-6.

  40. Qudsiya Z y Waseem M, Dermatomyositis, StatPearls, 2024:15-18.




2020     |     www.medigraphic.com